The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients

NCT ID: NCT00575445

Last Updated: 2015-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-11-30

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Pediatric patients with previously diagnosed asthma

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of asthma by pediatric pulmonologist
* Age 6-18 years

Exclusion Criteria

* Age \<6 years or \>18 years
* history of bronchopulmonary dysplasia
* history of cystic fibrosis
* history of primary ciliary dyskinesia
* current acute asthma exacerbation
* current acute viral upper respiratory infection
* recent ingestion of nitrate-rich foods
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Akron Children's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Akron Children's Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tiffany L Turner, MD

Role: PRINCIPAL_INVESTIGATOR

Pediatric resident at Akron Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Akron Children's Hospital

Akron, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Meyts I, Proesmans M, De Boeck K. Exhaled nitric oxide corresponds with office evaluation of asthma control. Pediatr Pulmonol. 2003 Oct;36(4):283-9. doi: 10.1002/ppul.10317.

Reference Type BACKGROUND
PMID: 12950039 (View on PubMed)

Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004 Jan;113(1):59-65. doi: 10.1016/j.jaci.2003.09.008.

Reference Type BACKGROUND
PMID: 14713908 (View on PubMed)

Olin AC, Aldenbratt A, Ekman A, Ljungkvist G, Jungersten L, Alving K, Toren K. Increased nitric oxide in exhaled air after intake of a nitrate-rich meal. Respir Med. 2001 Feb;95(2):153-8. doi: 10.1053/rmed.2000.1010.

Reference Type BACKGROUND
PMID: 11217912 (View on PubMed)

Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J. 2006 Aug;28(2):339-45. doi: 10.1183/09031936.06.00113705. Epub 2006 Apr 26.

Reference Type BACKGROUND
PMID: 16641119 (View on PubMed)

Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007 Apr;119(4):817-25. doi: 10.1016/j.jaci.2006.12.662. Epub 2007 Mar 13.

Reference Type BACKGROUND
PMID: 17353040 (View on PubMed)

Lara M, Duan N, Sherbourne C, Lewis MA, Landon C, Halfon N, Brook RH. Differences between child and parent reports of symptoms among Latino children with asthma. Pediatrics. 1998 Dec;102(6):E68. doi: 10.1542/peds.102.6.e68.

Reference Type BACKGROUND
PMID: 9832596 (View on PubMed)

Klein RB, Fritz GK, Yeung A, McQuaid EL, Mansell A. Spirometric patterns in childhood asthma: peak flow compared with other indices. Pediatr Pulmonol. 1995 Dec;20(6):372-9. doi: 10.1002/ppul.1950200607.

Reference Type BACKGROUND
PMID: 8649917 (View on PubMed)

Hoek G, Wypij D, Brunekreef B. Self-reporting versus parental reporting of acute respiratory symptoms of children and their relation to pulmonary function and air pollution. Int J Epidemiol. 1999 Apr;28(2):293-9. doi: 10.1093/ije/28.2.293.

Reference Type BACKGROUND
PMID: 10342694 (View on PubMed)

Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1523-8. doi: 10.1164/rccm.200502-253OC. Epub 2005 Sep 15.

Reference Type BACKGROUND
PMID: 16166623 (View on PubMed)

Franklin PJ, Turner SW, Mutch RC, Stick SM. Measuring exhaled nitric oxide in infants during tidal breathing: methodological issues. Pediatr Pulmonol. 2004 Jan;37(1):24-30. doi: 10.1002/ppul.10382.

Reference Type BACKGROUND
PMID: 14679485 (View on PubMed)

Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest. 2003 Mar;123(3):751-6. doi: 10.1378/chest.123.3.751.

Reference Type BACKGROUND
PMID: 12628874 (View on PubMed)

Corbelli R, Bringolf-Isler B, Amacher A, Sasse B, Spycher M, Hammer J. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest. 2004 Oct;126(4):1054-9. doi: 10.1378/chest.126.4.1054.

Reference Type BACKGROUND
PMID: 15486363 (View on PubMed)

Baraldi E, Bonetto G, Zacchello F, Filippone M. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med. 2005 Jan 1;171(1):68-72. doi: 10.1164/rccm.200403-298OC. Epub 2004 Oct 11.

Reference Type BACKGROUND
PMID: 15477497 (View on PubMed)

Antus B, Csiszer E, Czebe K, Horvath I. Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study. Clin Transplant. 2005 Jun;19(3):377-82. doi: 10.1111/j.1399-0012.2005.00354.x.

Reference Type BACKGROUND
PMID: 15877802 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

eNO/ACT Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Self Management Education Asthma
NCT00005712 TERMINATED